Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1997 Jan;56(1):37–40. doi: 10.1136/ard.56.1.37

Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis

J Tuokko 1, H Reijonen 1, J Ilonen 1, K Anttila 1, S Nikkari 1, T Mottonen 1, U Yli-Kerttula 1, A Toivanen 1
PMCID: PMC1752258  PMID: 9059139

Abstract

OBJECTIVE—To study HLA class II association in reactive arthritis.
METHODS—63 patients with reactive arth-ritis and 46 with rheumatoid arthritis were included in the study. HLA-DR alleles were determined by using a sequence specific PCR method. Oligonucleotide hybridisation was used for definition of DRB1*04 subtypes and DQB1 alleles. HLA-B27 was determined by standard microcytotoxity test or by PCR. HLA-B27 subtyping was made by sequencing.
RESULTS—46 (73%) of 63 patients with reactive arthritis were HLA-B27 positive and 24 (38%) were HLA-DRB1*04 positive. When haplotypes were inferred according to the known associations between DRB1 and DQB1 alleles, the frequency of DRB1*04-DQB1*0301 haplotype was found to be 13% (12/92) in HLA-B27 positive reactive arthritis patients, in contrast to 0% in HLA-B27 negative reactive arthritis (P = 0.04) and 1% in random controls (P = 0.0009). However, this combination was also found in 5% of 84 HLA-B27 positive control haplotypes, showing a linkage disequilibrium between B27 and this particular class II haplotype. HLA-DRB1*0408 subtype was found in 8/24 (33%) of the HLA-DRB1*04 alleles in patients with reactive arthritis, accounting for most DQB1*0301 haplotypes, but only in 5/55 (9%) of the DRB1*04 alleles in random controls (P = 0.017). All reactive arthritis patients with this subtype were positive for HLA-B27. DRB1*04-DQB1*0302 haplotype was increased in patients with rheumatoid arthritis (28/92, 30%) compared with reactive arthritis (12/126, 10%) or with the controls (12/100, 12%; P = 0.003). HLA-B*2705 was by far the dominant B27 subtype both in reactive arthritis patients with the particular DRB1*0408-DQB1*0301 haplotype and in controls. It was found in 11 out of 12 DR analysed patients, as well as in 10 out of 11 randomly selected B27 positive controls.
CONCLUSIONS—Although no single class II allele was found to be increased among patients with reactive arthritis, HLA-B27, DRB1*0408, and DQB1*0301 might exert a haplotypic effect in the pathogenesis of reactive arthritis, or they may be markers of a subset of B27 haplotypes conferring susceptibility.



Full Text

The Full Text of this article is available as a PDF (100.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Barron K. S., Reveille J. D., Carrington M., Mann D. L., Robinson M. A. Susceptibility to Reiter's syndrome is associated with alleles of TAP genes. Arthritis Rheum. 1995 May;38(5):684–689. doi: 10.1002/art.1780380517. [DOI] [PubMed] [Google Scholar]
  3. Bodmer J. G., Marsh S. G., Albert E. D., Bodmer W. F., Dupont B., Erlich H. A., Mach B., Mayr W. R., Parham P., Sasazuki T. Nomenclature for factors of the HLA system, 1994. Tissue Antigens. 1994 Jul;44(1):1–18. doi: 10.1111/j.1399-0039.1994.tb02351.x. [DOI] [PubMed] [Google Scholar]
  4. Chicz R. M., Urban R. G., Gorga J. C., Vignali D. A., Lane W. S., Strominger J. L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med. 1993 Jul 1;178(1):27–47. doi: 10.1084/jem.178.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dominguez O., Coto E., Martinez-Naves E., Choo S. Y., López-Larrea C. Molecular typing of HLA-B27 alleles. Immunogenetics. 1992;36(5):277–282. doi: 10.1007/BF00215655. [DOI] [PubMed] [Google Scholar]
  6. Hermann E., Yu D. T., Meyer zum Büschenfelde K. H., Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet. 1993 Sep 11;342(8872):646–650. doi: 10.1016/0140-6736(93)91760-j. [DOI] [PubMed] [Google Scholar]
  7. Ilonen J., Hakala M., Reijonen H., Tiilikainen A. B27-bearing HLA haplotypes in rheumatoid arthritis: characterization in Finnish patients. Hum Immunol. 1991 Jan;30(1):7–10. doi: 10.1016/0198-8859(91)90063-f. [DOI] [PubMed] [Google Scholar]
  8. Ilonen J., Reijonen H., Arvilommi H., Jokinen I., Möttönen T., Hannonen P. HLA-DR antigens and HLA-DQ beta chain polymorphism in susceptibility to rheumatoid arthritis. Ann Rheum Dis. 1990 Jul;49(7):494–496. doi: 10.1136/ard.49.7.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Inman R. D., Johnston M. E., Hodge M., Falk J., Helewa A. Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis. Arthritis Rheum. 1988 Nov;31(11):1377–1383. doi: 10.1002/art.1780311106. [DOI] [PubMed] [Google Scholar]
  10. Khan M. A. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol. 1995 Jul;7(4):263–269. doi: 10.1097/00002281-199507000-00001. [DOI] [PubMed] [Google Scholar]
  11. Khare S. D., Luthra H. S., David C. S. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med. 1995 Oct 1;182(4):1153–1158. doi: 10.1084/jem.182.4.1153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kingsley G., Sieper J. Current perspectives in reactive arthritis. Immunol Today. 1993 Aug;14(8):387–391. doi: 10.1016/0167-5699(93)90139-C. [DOI] [PubMed] [Google Scholar]
  13. Laivoranta S., Ilonen J., Tuokko J., Luukkainen R., Toivanen A. HLA frequencies in HLA-B27 negative patients with reactive arthritis. Clin Exp Rheumatol. 1995 Sep-Oct;13(5):637–640. [PubMed] [Google Scholar]
  14. Lanchbury J. S. The HLA association with rheumatoid arthritis. Clin Exp Rheumatol. 1992 May-Jun;10(3):301–304. [PubMed] [Google Scholar]
  15. López de Castro J. A. Structural polymorphism and function of HLA-B27. Curr Opin Rheumatol. 1995 Jul;7(4):270–278. doi: 10.1097/00002281-199507000-00002. [DOI] [PubMed] [Google Scholar]
  16. Maksymowych W. P., Tao S., Li Y., Wing M., Russell A. S. Allelic variation at the TAP 1 locus influences disease phenotype in HLA-B27 positive individuals with ankylosing spondylitis. Tissue Antigens. 1995 May;45(5):328–332. doi: 10.1111/j.1399-0039.1995.tb02462.x. [DOI] [PubMed] [Google Scholar]
  17. Mielants H., Veys E. M., Joos R., Noens L., Cuvelier C., De Vos M. HLA antigens in seronegative spondylarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation. J Rheumatol. 1987 Jun;14(3):466–471. [PubMed] [Google Scholar]
  18. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Monowarul Islam S. M., Numaga J., Fujino Y., Masuda K., Ohda H., Hirata R., Maeda H., Mitsui H. HLA-DR8 and acute anterior uveitis in ankylosing spondylitis. Arthritis Rheum. 1995 Apr;38(4):547–550. doi: 10.1002/art.1780380414. [DOI] [PubMed] [Google Scholar]
  20. Obst R., Armandola E. A., Nijenhuis M., Momburg F., Hämmerling G. J. TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur J Immunol. 1995 Aug;25(8):2170–2176. doi: 10.1002/eji.1830250808. [DOI] [PubMed] [Google Scholar]
  21. Olerup O. HLA-B27 typing by a group-specific PCR amplification. Tissue Antigens. 1994 Apr;43(4):253–256. doi: 10.1111/j.1399-0039.1994.tb02334.x. [DOI] [PubMed] [Google Scholar]
  22. Olerup O., Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992 May;39(5):225–235. doi: 10.1111/j.1399-0039.1992.tb01940.x. [DOI] [PubMed] [Google Scholar]
  23. Ploski R., Flatø B., Vinje O., Maksymowych W., Førre O., Thorsby E. Association to HLA-DRB1*08, HLA-DPB1*0301 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. Hum Immunol. 1995 Oct;44(2):88–96. doi: 10.1016/0198-8859(95)00063-a. [DOI] [PubMed] [Google Scholar]
  24. Sansom D. M., Bidwell J. L., Maddison P. J., Campion G., Klouda P. T., Bradley B. A. HLA DQ alpha and DQ beta restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritis. Hum Immunol. 1987 Aug;19(4):269–278. doi: 10.1016/0198-8859(87)90044-9. [DOI] [PubMed] [Google Scholar]
  25. Scofield R. H., Kurien B., Gross T., Warren W. L., Harley J. B. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet. 1995 Jun 17;345(8964):1542–1544. doi: 10.1016/s0140-6736(95)91089-1. [DOI] [PubMed] [Google Scholar]
  26. Singal D. P., D'Souza M., Reid B., Bensen W. G., Kassam Y. B., Adachi J. D. HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet. 1987 Nov 14;2(8568):1118–1120. doi: 10.1016/s0140-6736(87)91548-0. [DOI] [PubMed] [Google Scholar]
  27. Singal D. P., Green D., Reid B., Gladman D. D., Buchanan W. W. HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis. 1992 Jan;51(1):23–28. doi: 10.1136/ard.51.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Taurog J. D., Maika S. D., Simmons W. A., Breban M., Hammer R. E. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol. 1993 May 1;150(9):4168–4178. [PubMed] [Google Scholar]
  29. Victoria-Gutierrez M., Martinez-Naves E., Coto E., Dominguez O., Uría F., Urra J. M., López-Larrea C. DNA analysis of HLA-DR4B1 subtypes in multiple sclerosis by specific oligonucleotide probes. J Neuroimmunol. 1991 Jun;32(3):279–283. doi: 10.1016/0165-5728(91)90198-g. [DOI] [PubMed] [Google Scholar]
  30. Westman P., Partanen J., Leirisalo-Repo M., Koskimies S. Different DRB1*04 alleles predominate in the Finnish random population and in HLA-B27-positive subpopulations. Tissue Antigens. 1994 Nov;44(5):329–331. doi: 10.1111/j.1399-0039.1994.tb02405.x. [DOI] [PubMed] [Google Scholar]
  31. Westman P., Partanen J., Leirisalo-Repo M., Koskimies S. HSP70-Hom NcoI polymorphism and HLA-associations in the Finnish population and in patients with ankylosing spondylitis or reactive arthritis. Eur J Immunogenet. 1994 Apr;21(2):81–90. doi: 10.1111/j.1744-313x.1994.tb00179.x. [DOI] [PubMed] [Google Scholar]
  32. Zanelli E., Gonzalez-Gay M. A., David C. S. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today. 1995 Jun;16(6):274–278. doi: 10.1016/0167-5699(95)80181-2. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES